Brief: Shield Therapeutics No Longer Expects To Achieve Full Year Operating Profitability
03/11/2026 07:32
BRIEF-Shield Therapeutics No Longer Expects To Achieve Full Year Operating Profitability Nov 3 (Reuters) - Shield Therapeutics PLC STXS.L:
SHIELD THERAPEUTICS - Q3 2026 TRADING UPDATE
SHIELD THERAPEUTICS PLC: COMPANY NO LONGER EXPECTS GROUP TO ACHIEVE OPERATING PROFITABILITY FOR YEAR ENDING 31 DECEMBER 2026
SHIELD THERAPEUTICS - Q3 2026 GROUP NET REVENUE $11.50 MILLION, UP 2% QUARTER-ON-QUARTER EXCLUDING MILESTONE REVENUE
SHIELD THERAPEUTICS - EXPECTS SINGLE-DIGIT US$ MILLION LOSS FOR FY 2026
Source text: ID:nRSC5050Ba
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics No Longer Expects To Achieve Full Year Operating Profitability
Shield Therapeutics - Q3 2026 Trading Update
Brief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26